Neurohumoral Stimulation

Heart Failure Clinics

Volumn 8, Issue 1, 2012, Pages 87-99

  Zucker, Irving H ^a   Patel, Kaushik P ^a   Schultz, Harold D ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Baroreflex; Carotid body chemoreflex; Chronic heart failure; Neurohumoral activation; Sympathoexcitation

Indexed keywords

ALDOSTERONE; BENAZEPRIL; EPITHELIAL SODIUM CHANNEL; NEUROHORMONE; TOLVAPTAN;

CAROTID BODY; CAROTID SINUS PRESSORECEPTOR REFLEX; CHEMORECEPTOR REFLEX; CONGESTIVE HEART FAILURE; DEPRESSION; GLOMERULUS FILTRATION RATE; HUMAN; HYPONATREMIA; NONHUMAN; PRESSORECEPTOR REFLEX; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SOLITARY TRACT NUCLEUS;

ANIMALS; BAROREFLEX; CHEMORECEPTOR CELLS; DISEASE PROGRESSION; HEART FAILURE; HUMANS; NEUROTRANSMITTER AGENTS; SYMPATHETIC NERVOUS SYSTEM;

EID: 82955246195     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2011.08.007     Document Type: Review

References (132)

1. Esler M. The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 2010, 108:227-237.
2. Ruffolo R.R., Feuerstein G.Z. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. J Cardiovasc Pharmacol 1998, 32(Suppl 1):S22-S30.
3. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984, 311:819-823.
4. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990, 82:1724-1729.
5. Khaper N., Bryan S., Dhingra S., et al. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid Redox Signal 2010, 13:1033-1049.
6. Khullar M., Al-Shudiefat A.A., Ludke A., et al. Oxidative stress: a key contributor to diabetic cardiomyopathy. Can J Physiol Pharmacol 2010, 88:233-240.
7. Robinson T., Smith A., Channer K.S. Reversible heart failure: the role of inflammatory activation. Postgrad Med J 2011, 87(1024):110-115.
8. Castro P.F., Greig D., Pérez O., et al. Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003, 92:215-218.
9. Francis J., Yu L., Guggilam A., et al. Atorvastatin attenuates oxidative stress and improves neuronal nitric oxide synthase in the brain stem of heart failure mice. Circulation 2007, 116:II_157-II_158. [abstract 814].
10. Lindley T.E., Infanger D.W., Rishniw M., et al. Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1-R8.
11. Infanger D.W., Cao X., Butler S.D., et al. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 2010, 106:1763-1774.
12. Gao L., Wang W., Li Y.L., et al. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 2005, 288:H2271-H2279.
13. Ferguson D.W., Berg W.J., Sanders J.S., et al. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 1990, 16:1125-1134.
14. Meredith I.T., Eisenhofer G., Lambert G.W., et al. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993, 88:136-145.
15. Zucker I.H., Schultz H.D., Li Y.F., et al. The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol 2004, 84:217-232.
16. Eckberg D.L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971, 285:877-883.
17. Higgins C.B., Vatner S.F., Eckberg D.L., et al. Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest 1972, 51:715-724.
18. Chen J.-S., Wang W., Bartholet T., et al. Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure. Circulation 1991, 83:260-267.
19. Niebauer M.J., Holmberg M.J., Zucker I.H. Aortic baroreceptor characteristics in dogs with chronic high output failure. Basic Res Cardiol 1986, 81:111-122.
20. Niebauer M.J., Zucker I.H. Static and dynamic responses of carotid sinus baroreceptors in dogs with chronic volume overload. J Physiol (Lond) 1985, 369:295-310.
21. Wang W., Chen J.S., Zucker I.H. Postexcitatory depression of baroreceptors in dogs with experimental heart failure. Am J Physiol Heart Circ Physiol 1991, 260:H1160-H1165.
22. Wang W., Chen J., Zucker I.H. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 1990, 81:1959-1966.
23. Wang W., McClain J.M., Zucker I.H. Aldosterone reduces baroreceptor discharge in the dog. Hypertension 1992, 19:270-277.
24. Wang W., Chen J.S., Zucker I.H. Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ Res 1991, 68:1294-1301.
25. Grassi G., Seravalle G., Cattaneo B.M., et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995, 92:3206-3211.
26. Grassi G., Cattaneo B.M., Seravalle G., et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997, 96:1173-1179.
27. Brändle M., Patel K., Wang W., et al. Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sino-aortic denervated dogs. J Appl Physiol 1996, 81:1855-1862.
28. Levett J.M., Marinelli C.C., Lund D.D., et al. Effects of beta-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure. Am J Physiol Heart Circ Physiol 1994, 266:H468-H475.
29. Goetz K.L., Bond G.C., Bloxham D.D. Atrial receptors and renal function. Physiol Rev 1975, 55:157-205.
30. Schultz H.D., Fater D.C., Sundet W.D., et al. Reflexes elicited by acute stretch of atrial vs. pulmonary receptors in conscious dogs. Am J Physiol Heart Circ Physiol 1982, 242:H1065-H1076.
31. Farrow S., Banta G., Schallhorn S., et al. Vasopressin inhibits diuresis induced by water immersion in humans. J Appl Physiol 1992, 73(3):932-936.
32. Gabrielsen A., Sorensen V.B., Pump B., et al. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure. Am J Physiol Heart Circ Physiol 2000, 279:H1931-H1940.
33. Miki K., Yoshimoto M., Hayashida Y., et al. Role of cardiopulmonary and carotid sinus baroreceptors in regulating renal sympathetic nerve activity during water immersion in conscious dogs. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1807-R1812.
34. Gilmore J.P., Zucker I.H. Contribution of vagal pathways to the renal responses to head-out immersion in the nonhuman primate. Circ Res 1978, 42:263-267.
35. Anjuchovskij E.P., Beloshepko G.G., Yasinovskuya F.P. Characteristics of atrial mechanoreceptor and elastic features following heart failure. Sechenov Physiol J U S S R 1976, 62:1210-1215.
36. Brändle M., Wang W., Zucker I.H. Ventricular mechanoreflex and chemoreflex alterations in chronic heart failure. Circ Res 1994, 74:262-270.
37. Dibner-Dunlap M.E., Thames M.D. Atrial mechanoreflex control of renal sympathetic nerve activity (RNA) is blunted in heart failure. Circulation 1989, 80:II-393. [abstract].
38. Dibner-Dunlap M.E., Thames M.D. Control of sympathetic nerve activity by vagal mechanoreflexes is blunted in heart failure. Circulation 1992, 86:1929-1934.
39. von Scheidt W., Bohm M., Schneider B., et al. Cholinergic baroreflex vasodilatation: defect in heart transplant recipients due to denervation of the ventricular baroreceptor. Am J Cardiol 1992, 69:247-252.
40. Zucker I.H., Earle A.M., Gilmore J.P. Changes in the sensitivity of left atrial receptors following reversal of heart failure. Am J Physiol Heart Circ Physiol 1979, 237:H555-H559.
41. Zucker I.H., Share L., Gilmore J.P. Renal effects of left atrial distension in dogs with chronic congestive heart failure. Am J Physiol Heart Circ Physiol 1979, 236:H554-H560.
42. Zucker I.H., Earle A.M., Gilmore J.P. The mechanism of adaptation of left atrial stretch receptors in dogs with chronic congestive heart failure. J Clin Invest 1977, 60:323-331.
43. Mohanty P.K., Arrowood J.A., Ellenbogen K.A., et al. Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure. Am Heart J 1989, 118:78-85.
44. Notarius C.F., Morris B.L., Floras J.S. Dissociation between reflex sympathetic and forearm vascular responses to lower body negative pressure in heart failure patients with coronary artery disease. Am J Physiol Heart Circ Physiol 2009, 297:H1760-H1766.
45. Smith M.L., Ellenbogen K.A., Eckberg D.L., et al. Subnormal heart period variability in heart failure: effect of cardiac transplantation. J Am Coll Cardiol 1989, 14:106-111.
46. Zehr J.E., Hawe A., Tsakiris A.G., et al. ADH levels following nonhypotensive hemorrhage in dogs with chronic mitral stenosis. Am J Physiol 1971, 221:312-317.
47. Pliquett R.U., Cornish K.G., Patel K.P., et al. Amelioration of depressed cardiopulmonary reflex control of sympathetic nerve activity by short-term exercise training in male rabbits with heart failure. J Appl Physiol 2003, 95:1883-1888.
48. DiBona G.F., Herman P.J., Sawin L.L. Neural control of renal function in edema-forming states. Am J Physiol 1988, 254:R1017-R1024.
49. Mizelle H.L., Hall J.E., Montani J.P. Role of renal nerves in control of sodium excretion in chronic congestive heart failure. Am J Physiol Renal Physiol 1989, 256(25):F1084-F1093.
50. Patel K.P., Zhang P.L., Carmines P.K. Neural influences on renal responses to acute volume expansion in rats with heart failure. Am J Physiol Heart Circ Physiol 1996, 271:H1441-H1448.
51. Patel K.P., Zhang K., Carmines P.K. Norepinephrine turnover in peripheral tissues of rats with heart failure. Am J Physiol Regul Integr Comp Physiol 2000, 278:R556-R562.
52. Feng Q.P., Carlsson S., Thorén P., et al. Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat. Acta Physiol Scand 1994, 150:259-266.
53. Kidd C. Central neurons activated by cardiac receptors. Cardiac receptors 1979, 377-403. Cambridge University Press, Cambridge (MA). R. Hainsworth, C. Kidd, R.J. Linden (Eds.).
54. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983, 6:269-324.
55. Swanson L.W., Sawchenko P.E. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 1980, 31:410-417.
56. Haselton J.R., Goering J., Patel K.P. Parvocellular neurons of the paraventricular nucleus are involved in the reduction in renal nerve discharge during isotonic volume expansion. J Auton Nerv Syst 1994, 50:1-11.
57. Brody M.J., Johnson A.K. Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation and hypertension. Frontiers in neuroendocrinology 1980, 249-292. Raven, New York. L. Martini, W.F. Ganong (Eds.).
58. Patel K.P. Neural regulation in experimental heart failure. Baillieres Clin Neurol 1997, 6:283-296.
59. Patel K.P., Zhang P.L., Krukoff T.L. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol 1993, 265:R923-R928.
60. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988, 77:721-730.
61. Hodsman G.P., Kohzuki M., Howes L.G., et al. Neurohumoral responses to chronic myocardial infarction in rats. Circulation 1988, 78:376-381.
62. Goldsmith S.R., Francis G.S., Cowley A.W., et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol 1983, 1:1385-1390.
63. Berl T., Quittnat-Pelletier F., Verbalis J.G., et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 2010, 21:705-712.
64. Zheng H., Li Y.F., Weiss M., et al. Neuronal expression of fos protein in the forebrain of diabetic rats. Brain Res 2002, 956:268-275.
65. Li Y.F., Mayhan W.G., Patel K.P. Role of the paraventricular nucleus in renal excretory responses to acute volume expansion: role of nitric oxide. Am J Physiol Heart Circ Physiol 2003, 285:H1738-H1746.
66. Li Y.F., Patel K.P. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand 2003, 177:17-26.
67. Zhang K., Li Y.F., Patel K.P. Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure. Am J Physiol Heart Circ Physiol 2001, 281:H995-H1004.
68. Kohzuki M., Hodsman G.P., Johnston C.I. Attenuated response to atrial natriuretic peptide in rats with myocardial infarction. Am J Physiol 1989, 256:H533-H538.
69. Pedersen E.B., Danielsen H., Jensen T., et al. Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure. Eur J Clin Invest 1986, 16:56-60.
70. Masilamani S., Kim G.H., Mitchell C., et al. Aldosterone-mediated regulation of ENaC alpha, beta and gamma subunit proteins in rat kidney. J Clin Invest 1999, 104:19-23.
71. Ecelbarger C.A., Kim G.H., Terris J., et al. Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. Am J Physiol Renal Physiol 2000, 270:F46-F53.
72. Zheng H., Liu X., Rao U.S., et al. Increased renal ENaC subunits and sodium retention in rats with chronic heart failure. Am J Physiol Renal Physiol 2011, 300:F641-F649.
73. Kumagai K., Reid I.A. Losartan inhibits sympathetic and cardiovascular responses to carotid occlusion. Hypertension 1994, 23:827-831.
74. Quillen E.W., Reid I.A. Intravertebral ANG II effects on plasma renin and Na excretion in dogs at constant renal artery pressure. Am J Physiol 1995, 268:F296-F301.
75. Reid I.A. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol Endocrinol Metab 1992, 262:E763-E778.
76. Xu L., Brooks V.L. ANG II chronically supports renal and lumbar sympathetic activity in sodium-deprived, conscious rats. Am J Physiol Heart Circ Physiol 1996, 271:H2591-H2598.
77. Zucker I.H., Wang W., Pliquett R.U., et al. The regulation of sympathetic outflow in heart failure. Neuro-cardiovascular regulation 2001, 431-443. New York Academy of Sciences, New York. M.W. Chapleau, F.M. Abboud (Eds.).
78. Cardin S., Li D., Thorin-Trescases N., et al. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003, 60:315-325.
79. Zucker I.H., Schultz H.D., Patel K.P., et al. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol 2009, 297:H1557-H1566.
80. Grobe J.L., Xu D., Sigmund C.D. An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda) 2008, 23:187-193.
81. Gao L., Wang W., Li Y.L., et al. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 2004, 95:937-944.
82. Liu D., Gao L., Roy S.K., et al. Neuronal AT1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 2006, 99:1004-1011.
83. Kang Y.M., Ma Y., Elks C., et al. Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc Res 2008, 79:671-678.
84. Wang W.Z., Gao L., Wang H.J., et al. Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the NTS AT1 receptors in heart failure. Am J Physiol Heart Circ Physiol 2008, 295:H1216-H1226.
85. Gao L., Wang W.Z., Wang W., et al. Imbalance of angiotensin receptor expression and function in the RVLM: Potential mechanism for sympathetic overactivity in heart failure. Hypertension 2008, 52:708-714.
86. Kar S., Gao L., Zucker I.H. Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing induced heart failure. J Appl Physiol 2010, 108:923-934.
87. Zimmerman M.C., Dunlay R.P., Lazartigues E., et al. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004, 95:532-539.
88. Zimmerman M.C., Lazartigues E., Lang J.A., et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002, 91:1038-1045.
89. Ma R., Zucker I.H., Wang W. Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. Am J Physiol Heart Circ Physiol 1997, 273:H2664-H2671.
90. Wang W., Zucker I.H. Cardiac sympathetic afferent reflex in dogs with congestive heart failure. Am J Physiol 1996, 271:R751-R756.
91. Wang W., Schultz H.D., Ma R. Cardiac sympathetic afferent sensitivity is enhanced in heart failure. Am J Physiol Heart Circ Physiol 1999, 277(46):H812-H817.
92. Wang W., Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev 2000, 5:57-71.
93. Fu L.W., Longhurst J.C. Regulation of cardiac afferent excitability in ischemia. Handb Exp Pharmacol 2009, 194:185-225.
94. Wang W. Cardiac sympathetic afferent stimulation by bradykinin in heart failure: role of NO and prostaglandins. Am J Physiol 1998, 275:H783-H788.
95. Wang W., Schultz H.D., Ma R. Volume expansion potentiates cardiac sympathetic afferent reflex in dogs. Am J Physiol Heart Circ Physiol 2001, 280:H576-H581.
96. Ma R., Zhu G.Q., Wang W. Interaction of central Ang II and NO on the cardiac sympathetic afferent reflex in dogs. Auton Neurosci 2005, 118:51-60.
97. Ma R., Zucker I.H., Wang W. Reduced NO enhances the central gain of cardiac sympathetic afferent reflex in dogs with heart failure. Am J Physiol 1999, 276:H19-H26.
98. Ma R., Schultz H.D., Wang W. Chronic central infusion of ANG II potentiates cardiac sympathetic afferent reflex in dogs. Am J Physiol Heart Circ Physiol 1999, 277:H15-H22.
99. Zhu G.Q., Gao L., Patel K.P., et al. ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J Appl Physiol 2004, 97:1746-1754.
100. Wang W.Z., Gao L., Pan Y.X., et al. Differential effects of cardiac sympathetic afferent stimulation on neurons in the nucleus tractus solitarius. Neurosci Lett 2006, 409:146-150.
101. Zhu G.Q., Gao X.Y., Zhang F., et al. Reduced nitric oxide in the rostral ventrolateral medulla enhances cardiac sympathetic afferent reflex in rats with chronic heart failure. Sheng Li Xue Bao 2004, 56:47-53.
102. Gao L., Schultz H.D., Patel K.P., et al. Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure. Hypertension 2005, 45:1173-1181.
103. Ponikowski P., Chua T.P., Pepoli M., et al. Augmented peripheral chemosensitiviy as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 1997, 96:2586-2594.
104. Sun S.Y., Wang W., Zucker I.H., et al. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 1999, 86(4):1264-1272.
105. Sun S.Y., Zucker I.H., Wang W., et al. Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 1999, 86(4):1273-1282.
106. Schultz H.D., Li Y.L. Carotid body function in heart failure. Respir Physiol Neurobiol 2007, 157:171-185.
107. Li Y.L., Xia X.H., Zheng H., et al. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc Res 2006, 71:129-138.
108. Li Y.L., Gao L., Zucker I.H., et al. NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovasc Res 2007, 75:546-554.
109. Ding Y., Li Y.L., Zimmerman M.C., et al. Elevated mitochondrial superoxide contributes to enhanced chemoreflex in heart failure rabbits. Am J Physiol Regul Integr Comp Physiol 2010, 298:R303-R311.
110. Ding Y., Li Y.L., Zimmerman M.C., et al. Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Cardiovasc Res 2009, 81:678-685.
111. Li Y.L., Li Y.F., Liu D., et al. Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits. Circ Res 2005, 97:260-267.
112. Li Y.L., Schultz H.D. Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II. J Physiol 2006, 575:215-227.
113. Li Y.L., Sun S.Y., Overholt J.L., et al. Attenuated outward potassium currents in carotid body glomus cells of heart failure rabbit: involvement of nitric oxide. J Physiol 2004, 555:219-229.
114. Li Y.L., Zheng H., Ding Y., et al. Expression of neuronal nitric oxide synthase in rabbit carotid body glomus cells regulates large-conductance Ca2+-activated potassium currents. J Neurophysiol 2010, 103:3027-3033.
115. Ding Y., Li Y.L., Schultz H.D. Role of blood flow in carotid body chemoreflex function in heart failure. J Physiol 2011, 589:245-258.
116. Schmidt H., Francis D.P., Rauchhaus M., et al. Chemo- and ergoreflexes in health, disease and ageing. Int J Cardiol 2005, 98:369-378.
117. Sinoway L.I., Li J. A perspective on the muscle reflex: implications for congestive heart failure. J Appl Physiol 2005, 99:5-22.
118. Smith S.A., Mitchell J.H., Garry M.G. The mammalian exercise pressor reflex in health and disease. Exp Physiol 2006, 91:89-102.
119. Coats A.J. The " muscle hypothesis" of chronic heart failure. J Mol Cell Cardiol 1996, 28:2255-2262.
120. Middlekauff H.R., Sinoway L.I. Increased mechanoreceptor/metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol 2007, 102:492-494.
121. Li J., Sinoway A.N., Gao Z., et al. Muscle mechanoreflex and metaboreflex responses after myocardial infarction in rats. Circulation 2004, 110:3049-3054.
122. Smith S.A., Mitchell J.H., Naseem R.H., et al. Mechanoreflex mediates the exaggerated exercise pressor reflex in heart failure. Circulation 2005, 112:2293-2300.
123. Sterns D.A., Ettinger S.M., Gray K.S., et al. Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure. Circulation 1991, 84:2034-2039.
124. Piepoli M.F., Coats A.J. Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol 2007, 102:494-496.
125. Silber D.H., Sutliff G., Yang Q.X., et al. Altered mechanisms of sympathetic activation during rhythmic forearm exercise in heart failure. J Appl Physiol 1998, 84:1551-1559.
126. Scott A.C., Davies L.C., Coats A.J., et al. Relationship of skeletal muscle metaboreceptors in the upper and lower limbs with the respiratory control in patients with heart failure. Clin Sci (Lond) 2002, 102:23-30.
127. Wang H.J., Li Y.L., Gao L., et al. Alteration in skeletal muscle afferents in rats with chronic heart failure. J Physiol 2010, 588:5033-5047.
128. Smith S.A., Williams M.A., Mitchell J.H., et al. The capsaicin-sensitive afferent neuron in skeletal muscle is abnormal in heart failure. Circulation 2005, 111:2056-2065.
129. Koba S., Xing J., Sinoway L.I., et al. Bradykinin receptor blockade reduces sympathetic nerve response to muscle contraction in rats with ischemic heart failure. Am J Physiol Heart Circ Physiol 2010, 298:H1438-H1444.
130. Middlekauff H.R., Chiu J., Hamilton M.A., et al. Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure. Am J Physiol Heart Circ Physiol 2008, 294:H1956-H1962.
131. Koba S., Gao Z., Sinoway L.I. Oxidative stress and the muscle reflex in heart failure. J Physiol 2009, 587:5227-5237.
132. Schunk K., Kersjes W., Schadmand-Fischer S., et al. Rofo 1997, 166:317-323. [in German].